Résumé :
|
[BDSP. Notice produite par INIST-CNRS PR0xKjM5. Diffusion soumise à autorisation]. Objectives : This study evaluated the effect of comorbidity at diagnosis on racial differences in survival among men with prostate cancer. Methods : Clinical and demographic data were abstracted from records of 864 patients diagnosed at 4 Chicago area hospitals between 1986 and 1990. Comorbidity was scored on the basis of clinical information in the Charlson index. Cause-specific relative mortality adjusted for age, stage, differentiation, and treatment was compared across Charlson scores with Cox proportional hazards functions. Results : Blacks had significantly greater mortality from prostate cancer and other causes (vs Whites, relative risk [95% confidence interval]=1.84 [1.22,2.791 and 1.69 [1.33,2.29], respectively ; P<. 001). However, differences disappeared as initial comorbidity increased (1.75 [1.33,2.31] vs 0.90 [0.59,1.29] for scores=0 and>=5, respectively). Conclusions : Absence of a significant preexisting medical diagnosis is associated with a higher risk for excess mortality among Black men diagnosed with prostate cancer.
|